Nexalin Technology (NXL) Return on Sales [ROS] (2021 - 2026)
Nexalin Technology's Return on Sales [ROS] was -18479.69% in Q2 2026, down 16183.47 percentage points from -2296.22% a year earlier and down 4299.74 percentage points from the prior quarter.
Nexalin Technology (NXL) Return on Sales [ROS] (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Nexalin Technology's Return on Sales [ROS] was -4202.54% through Jun 30, 2026, up 954.97 percentage points year-over-year; for FY2025, it was -2781.69%, up 1814.45 percentage points from FY2024.
- Return on Sales [ROS] shows a four-year change of +1396.01 percentage points (FY2021 to FY2025).
- In earlier years, Return on Sales [ROS] was -4596.14% in FY2024 (+547.34 pp), -5143.48% in FY2023 (-5004.75 pp), -138.72% in FY2022 (+4038.97 pp) and -4177.70% in FY2021.
- The Q2 2026 figure marks the lowest quarterly Return on Sales [ROS] in data going back to Q3 2021.
- Compared with a year earlier, Return on Sales [ROS] was higher in three of the last eight quarters, with an average year-over-year change of -2857.83 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q4 2025 (a gain of 9175.62 percentage points); the worst was Q2 2026 (a drop of 16183.47 percentage points).
- Per Business Quant data, NXL's Return on Sales [ROS] in the three quarters before Q2 2026 was -14179.95% (Q1 2026), -1403.86% (Q4 2025) and -12924.30% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 17.40% |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | 13.44% |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | 17.99% |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 33.60% |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 18.08% |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | 25.18% |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | 21.65% |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | 29.48% |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | 13.31% |
| 10 | Nexalin Technology | 4.20 Mn | -7.59 Mn | 8,897.00 | -18,479.69% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18,479.69% |
| Mar 31, 2026 | -14,179.95% |
| Dec 31, 2025 | -1,403.86% |
| Sep 30, 2025 | -12,924.30% |
| Jun 30, 2025 | -2,296.22% |
| Mar 31, 2025 | -4,903.63% |
| Dec 31, 2024 | -10,579.48% |
| Sep 30, 2024 | -6,962.11% |
| Jun 30, 2024 | -4,832.42% |
| Mar 31, 2024 | -1,364.81% |
| Dec 31, 2023 | -7,910.37% |
| Sep 30, 2023 | -10,017.57% |
| Jun 30, 2023 | -2,467.25% |
| Mar 31, 2023 | -2,550.48% |
| Dec 31, 2022 | -1,872.83% |
| Sep 30, 2022 | -53.77% |
| Jun 30, 2022 | -107.44% |
| Mar 31, 2022 | -116.02% |
| Dec 31, 2021 | -2,406.30% |
| Sep 30, 2021 | -3,207.88% |
Nexalin Technology Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "NXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();